DNA and RNA Banking Services Market
The market for DNA and RNA Banking Services was estimated at $7.9 billion in 2024; it is anticipated to increase to $11.0 billion by 2030, with projections indicating growth to around $14.6 billion by 2035.
Global DNA and RNA Banking Services Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The DNA and RNA Banking Services industry revenue is expected to be around $8.4 billion in 2025 and expected to showcase growth with 5.7% CAGR between 2025 and 2034. The substantial expansion in the DNA and RNA Banking Services sector is mainly fueled by the growing importance of research in diagnosing and treating diseases. The continuous importance of the market is underlined by the increasing need for personalized medicine. The increase in genetic disorders and the increased focus on preserving genetic material for future applications. Technological advancements in biobanking and increased funding, for genomics research are also significant factors driving market growth.
DNA and RNA banking services encompass the gathering, handling, preserving and dispersal of DNA and RNA specimens. These services play a role in multiple fields such as healthcare, farming and forensic science. Important aspects of these services consist of top notch sample conservation, rigorous quality assurance protocols and safe storage infrastructures. Primary uses span from investigations, medication exploration and innovation, to illness detection and therapy.
Market Key Insights
- The DNA and RNA Banking Services market is projected to grow from $7.9 billion in 2024 to $13.8 billion in 2034. This represents a CAGR of 5.7%, reflecting rising demand across Genomic Research, Forensic Science and Personalized Medicine.
- Thermo Fisher Scientific Inc., QIAGEN N.V., Brooks Automation Inc. are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the DNA and RNA Banking Services market and are expected to observe the growth CAGR of 3.7% to 5.5% between 2024 and 2030.
- Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 6.6% to 7.9%.
- Transition like Technological Advancements has greater influence in U.S. and Germany market's value chain; and is expected to add $347 million of additional value to Dna And Rna Banking Services industry revenue by 2030.
- The DNA and RNA Banking Services market is set to add $5.9 billion between 2024 and 2034, with manufacturer targeting Pharmaceutical Companies & Research Institutes Applications projected to gain a larger market share.
- With Advancements in genomic research, and Increasing prevalence of genetic disorders, DNA and RNA Banking Services market to expand 74% between 2024 and 2034.